Benjamin Kahn
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 2
- Angiogenesis and VEGF in Cancer 1
- Glycosylation and Glycoproteins Research 1
- Single-cell and spatial transcriptomics 1
- Oncology 4
- PARP inhibition in cancer therapy 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Ben Z. Stanger (6 shared papers)Jinyang Li (2 shared papers)Robert S. Krauss (1 shared paper)Alfredo Lucas (4 shared papers)Mingi Hong (1 shared paper)Douglas J. Epstein (1 shared paper)Robert B. Faryabi (1 shared paper)Kenneth P. Olive (1 shared paper)
- Journals
- Nature Communications (1 paper)Clinical Schizophrenia & Related Psychoses (1 paper)Journal of Drugs in Dermatology (1 paper)Journal of Clinical Investigation (1 paper)Disease Models & Mechanisms (1 paper)
- Partner nations
- United StatesSlovakiaCanada
In The Last Decade
Benjamin Kahn
10 papers receiving 122 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 22
- Oncology 35
- Immunology 19
- Ophthalmology 6
- Molecular Biology 47
Countries citing papers authored by Benjamin Kahn
This map shows the geographic impact of Benjamin Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Kahn more than expected).
Fields of papers citing papers by Benjamin Kahn
This network shows the impact of papers produced by Benjamin Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Kahn. The network helps show where Benjamin Kahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Kahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 37 | |
| 2 | 2016 | 24 | |
| 3 | 2024 | 21 | |
| 4 | 2021 | 13 | |
| 5 | 2024 | 13 | |
| 6 | 2018 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2018 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2025 | 2 | |
| 11 | 2025 | 0 |
About Benjamin Kahn
Benjamin Kahn is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Dermatology, having authored 11 papers that have together received 123 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), PARP inhibition in cancer therapy (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Glycosylation and Glycoproteins Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Immunotherapy and Immune Responses (1 paper), Schizophrenia research and treatment (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Cancer Research (22 citations), Oncology (35 citations), Immunology (19 citations), Ophthalmology (6 citations) and Molecular Biology (47 citations). Benjamin Kahn has collaborated with scholars based in United States, Slovakia and Canada. Frequent co-authors include Ben Z. Stanger, Jinyang Li, Robert S. Krauss, Alfredo Lucas, Mingi Hong, Douglas J. Epstein, Robert B. Faryabi, Kenneth P. Olive, Gregory W. Schwartz and H. Carlo Maurer. Their work appears in journals such as Nature Communications, Clinical Schizophrenia & Related Psychoses, Journal of Drugs in Dermatology, Journal of Clinical Investigation and Disease Models & Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.